| Literature DB >> 35456400 |
Ovidiu Aghiorghiesei1,2, Oana Zanoaga2, Andreea Nutu2, Cornelia Braicu2, Radu Septimiu Campian3, Ondine Lucaciu1, Ioana Berindan Neagoe2.
Abstract
Oral cancer is one of the leading causes of death worldwide, with a reported 5-year survival rate of around 50% after treatment. Epigenetic modifications are considered to have a key role in oral carcinogenesis due to histone modifications, aberrant DNA methylation, and altered expression of miRNAs. MicroRNAs (miRNAs) are small non-coding RNAs that have a key role in cancer development by regulating signaling pathways involved in carcinogenesis. MiRNA deregulation identified in oral cancer has led to the idea of using them as potential biomarkers for early diagnosis, prognosis, and the development of novel therapeutic strategies. In recent years, a key role has been observed for risk factors in preventing and treating this malignancy. The purpose of this review is to summarize the recent knowledge about the altered mechanisms of oral cancer due to risk factors and the role of miRNAs in these mechanisms.Entities:
Keywords: epigenetics; miRNAs; oral cancer; risk factors
Mesh:
Substances:
Year: 2022 PMID: 35456400 PMCID: PMC9027895 DOI: 10.3390/genes13040594
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.141
Figure 1The link between the main factors related to oral carcinogenesis, including environmental, risk/epigenetic factors, genetic background, and age.
The main miRNAs related to risk factors in oral carcinogenesis.
| Risk Factor | Tumor Type | miR | Targets | Effects/Clinical Significance | References |
|---|---|---|---|---|---|
| smoking | OSCC | miR-31-5p↑ | SLC16A1 | Cancer cell proliferation | [ |
| OSCC | miR-30a↓ | DNMT3B | Growth inhibition in oral cancer cells | [ | |
| OSCC | miR-944↑ | CISH | Maintaining a pro-carcinogenic microenvironment in oral cancer | [ | |
| OSCC | miR-200a, miR-200b, miR-200c, miR-141 and miR-429, ↓ | ZEB2-AS1 and ZEB2 | No significant effect on treatment outcome | [ | |
| HNSCC | miR-101-1, miR-181b-1, miR-486, and miR-1301↑ | Increase of cell proliferation, metastasis, and decrease in survival | [ | ||
| alcohol | HNSCC | miR-375↑ | Decrease in survival | [ | |
| OSCC | miR-34a↓ | P53 | Inhibition of tumor growth | [ | |
| miR-30a↑miR-934↑ | BCL-2 | Increase in cellular proliferation | [ | ||
| betel/tobacco chewing | OSCC | miR-155↑ | Increase in cellular proliferation | [ | |
| OSCC | miR-486-3p↓ | DDR1 | Growth inhibition and apoptosis induction | [ | |
| OSCC | miR-30a↓ | DNMT3B | Growth inhibition in oral cancer cells | [ | |
| OSCC | miR-29c-3p miR-146a-5p↑ | SLC2A14 | Cancer cells proliferation | [ | |
| OSCC | miR329 and miR410↓ | Wnt-7b | Proliferation and invasion of cells | [ | |
| Areca nut | OSCC | miR-23a↑ | FANCG | Induction of cell proliferation | [ |
| OSCC | miR-22↓ | OSM | Promote cell proliferation and cell-cycle progression | [ | |
| pan-masala chewing | OSCC | miR-21↑ | Poor prognosis | [ | |
| HPV | TSCC/BOTSCC | miR-155↑ | CD8+ TIL | Decreased survival | [ |
| OSCC | miR-550a-3-5p↓ | YAP | Larger tumor size and nodal metastasis | [ | |
| HNSCC | miR-9↑ | Proliferation and migration of the cells | [ | ||
| HNSCC | miR-99a-3p and miR-4746-5p↑ | MAPK | Improvement of overall survival | [ | |
| OPSCC | miR-133a-3p↓ | EGFR and HuR | Promote cell proliferation | [ | |
| OSCC | let-7e↑ | βCatenin | Induction of stem-like traits in tobacco-related OSCCs | [ | |
| SARS-CoV-2 | HNSCC | miR-193b-3p; miR-503-5p; | TMPRSS2 | Resistance to SARS-CoV-2 infection | [ |
| EBV | NPC | EBV-miR-BART1↑ | G6PD, SAT1, ASS1, PAST1, FUT1, SGPL1, DHRS3, PHGDH, GALNT1 | Tumor metastasis | [ |
| NPC | miR-BART7-3p↑ | SMAD7 | Drug resistance and cancer recurrence | [ |
Abbreviations: TSCC/BOTSCC, tonsillar and base of tongue cancer; OSCC, oral squamous cell carcinoma; HNSCCs, head, and neck squamous cell carcinomas; OSM, oncostatin M; oropharyngeal squamous cell carcinoma (OPSCC); DNMT3B, DNA Methyltransferase 3 β; CISH, Cytokine Inducible SH2 Containing Protein; STAT3, Signal Transducer And Activator Of Transcription 3; ZEB2, Zinc Finger E-Box Binding Homeobox 2; ZEB2-AS1, ZEB2 Antisense RNA 1; BCL2, BCL2 Apoptosis Regulator; DDR1, Discoidin Domain Receptor Tyrosine Kinase 1; epidermal growth factor receptor (EGFR); SLC2A14, Solute Carrier Family 2 Member 14; MX2, MX Dynamin Like GTPase 2; OASL, 2′-5′-oligoadenylate synthase-like protein; YAP, Yes1 Associated Transcriptional Regulator HuR; FOXO1, Forkhead Box O1; TMPRSS2, Transmembrane Serine Protease 2; ASS1,Argininosuccinate Synthase 1; FUT1, Fucosyltransferase 1 (H Blood Group); SGPL1 (Sphingosine-1-Phosphate Lyase 1); DHRS3, dehydrogenase/reductase 3; PHGDH, Phosphoglycerate Dehydrogenase; RBP Hu-antigen R; GALNT1, Polypeptide N-Acetylgalactosaminyltransferase 1; NPC, nasopharyngeal carcinoma.
Figure 2The connection between miRNAs and the main risk factors in oral cancer.